This Pathway to Independence Award application is submitted by a pulmonary and critical care epidemiologist committed to improving the quality of patient-oriented research for patients experiencing acute respiratory failure (ARF). Worldwide, millions of patients develop ARF annually. In the U.S., nearly one million patients with ARF require mechanical ventilation annually, accounting for a quarter of all intensive care unit (ICU) admissions. As improvements in ICU care reduce such patients? in-hospital mortality rates, attention has shifted to the challenges ARF survivors face in regaining their prior cognitive, physical, and psychosocial functioning. However, there is a key barrier for randomized clinical trials (RCTs) testing new interventions to improve ARF survivorship ? that is, the current lack of an endpoint that (1) captures long-term patient dispositions, (2) incorporates patient preferences and perspectives, and (3) is able to be analyzed without concern for statistical biases. The overarching goal of this research is to support clinical innovation by developing new approaches to measure and report long-term patient-centered outcomes that overcome the methodological barriers currently limiting ARF RCTs. The applicant will accomplish his goals under the mentorship of established researchers in critical care, patient-centered outcomes research, statistics, and informatics to assure his transition to a tenure-track faculty position in the R00 phase and his emergence as a leading pulmonary and critical care epidemiologist. First, the applicant will use an innovative combination of qualitative and quantitative research methods to elicit and integrate ARF survivors? and their caregivers? perspectives into a new patient-centered, long-term composite outcome measure (K99 phase). During the R00 phase, the applicant will recruit ARF survivors to participate in a prospective cohort, and follow these patients to describe the burden of ARF survivorship over 1-year using the new endpoint developed during the K99 phase. This endeavor will also provide key data that will facilitate sample size calculations in future ARF RCTs. Data from this cohort will additionally be used to develop an electronic health record (EHR)-based algorithm to predict risks for adverse long-term outcomes among ARF patients early in their ICU stays. Thus, this K99/R00 will augment ARF research by establishing a new outcome measure anchored in patient perspectives, improving the understanding and clinical prognostication of post-ICU morbidity following ARF, and facilitate the efficiency and clinical relevance of future ARF RCTs by enabling measurement of patients? baseline risks for different outcomes. Concurrently, the didactic work, individual study, and hands-on learning in mixed-methods research, natural language processing, and predictive analytics will fill key training gaps for the applicant, thereby positioning him for a successful, independently-funded research career advancing the science of outcomes measurement and analysis for ARF RCTs.

Public Health Relevance

Randomized trials testing strategies to improve long-term outcomes for survivors of acute respiratory failure (ARF) are hampered by the lack of valid, patient-centered endpoints. Using interviews with ARF survivors and their caregivers, statistical simulation, consensus building among stakeholders, and a prospective cohort study, the applicant will develop, describe the epidemiology of, and predict a new patient-oriented outcome that will support trials of innovative approaches to improve ARF survivorship outcomes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Career Transition Award (K99)
Project #
1K99HL141678-01
Application #
9505095
Study Section
NHLBI Mentored Transition to Independence Review Committee (MTI)
Program Officer
Reineck, Lora A
Project Start
2018-04-15
Project End
2020-03-31
Budget Start
2018-04-15
Budget End
2019-03-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Biostatistics & Other Math Sci
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Harhay, Michael O; Porcher, Raphaƫl; Thabut, Gabriel et al. (2018) Donor Lung Sequence Number and Survival after Lung Transplantation in the United States. Ann Am Thorac Soc :
Weissman, Gary E; Ungar, Lyle H; Harhay, Michael O et al. (2018) Construct validity of six sentiment analysis methods in the text of encounter notes of patients with critical illness. J Biomed Inform :
Kohn, Rachel; Harhay, Michael O; Bayes, Brian et al. (2018) Ward Capacity Strain: A Novel Predictor of 30-Day Hospital Readmissions. J Gen Intern Med 33:1851-1853
Adeloye, Davies; Harhay, Michael O; Ayepola, Olayemi O et al. (2018) Estimate of the incidence of bladder cancer in Africa: A systematic review and Bayesian meta-analysis. Int J Urol :
Detsky, Michael E; Kohn, Rachel; Delman, Aaron M et al. (2018) Patients' perceptions and ICU clinicians predictions of quality of life following critical illness. J Crit Care 48:352-356
Kohn, Rachel; Harhay, Michael O; Weissman, Gary E et al. (2018) Ward Capacity Strain: A Novel Predictor of Delays in Intensive Care Unit Survivor Throughput. Ann Am Thorac Soc :
Harhay, Meera N; Harhay, Michael O; Ranganna, Karthik et al. (2018) Association of the kidney allocation system with dialysis exposure before deceased donor kidney transplantation by preemptive wait-listing status. Clin Transplant 32:e13386
Harhay, Michael O; Troxel, Andrea B; Brophy, Christine et al. (2018) Financial Incentives Promote Smoking Cessation Directly, Not by Increasing Use of Cessation Aids. Ann Am Thorac Soc :